- Home
- PRA vs ORIC Comparison
PRA vs ORIC Comparison
Compare PRA & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRA
- ORIC
- Stock Information
- Founded
- PRA 1976
- ORIC 2014
- Country
- PRA United States
- ORIC United States
- Employees
- PRA N/A
- ORIC N/A
- Industry
- PRA Property-Casualty Insurers
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- PRA Finance
- ORIC Health Care
- Exchange
- PRA Nasdaq
- ORIC Nasdaq
- Market Cap
- PRA 1.2B
- ORIC 974.1M
- IPO Year
- PRA N/A
- ORIC 2020
- Fundamental
- Price
- PRA $23.77
- ORIC $10.88
- Analyst Decision
- PRA Hold
- ORIC Strong Buy
- Analyst Count
- PRA 4
- ORIC 10
- Target Price
- PRA $21.00
- ORIC $17.33
- AVG Volume (30 Days)
- PRA 446.0K
- ORIC 782.2K
- Earning Date
- PRA 08-05-2025
- ORIC 08-12-2025
- Dividend Yield
- PRA N/A
- ORIC N/A
- EPS Growth
- PRA N/A
- ORIC N/A
- EPS
- PRA 0.95
- ORIC N/A
- Revenue
- PRA $1,128,928,000.00
- ORIC N/A
- Revenue This Year
- PRA N/A
- ORIC N/A
- Revenue Next Year
- PRA N/A
- ORIC N/A
- P/E Ratio
- PRA $25.04
- ORIC N/A
- Revenue Growth
- PRA N/A
- ORIC N/A
- 52 Week Low
- PRA $12.43
- ORIC $3.90
- 52 Week High
- PRA $24.14
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- PRA 46.88
- ORIC 63.04
- Support Level
- PRA $23.62
- ORIC $9.87
- Resistance Level
- PRA $23.87
- ORIC $10.35
- Average True Range (ATR)
- PRA 0.11
- ORIC 0.44
- MACD
- PRA -0.03
- ORIC 0.14
- Stochastic Oscillator
- PRA 30.00
- ORIC 79.99
About PRA ProAssurance Corporation
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.